CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
BERKELEY HEIGHTS, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
BERKELEY HEIGHTS, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
BERKELEY HEIGHTS, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third…
Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third…
Patent developed in collaboration with Syngene International Ltd. MINNEAPOLIS, Sept. 26, 2023 (GLOBE NEWSWIRE) —…
Patent developed in collaboration with Syngene International Ltd. MINNEAPOLIS, Sept. 26, 2023 (GLOBE NEWSWIRE) —…
Submission based on positive results from Phase 3 PHALCON-NERD-301 in which vonoprazan 10 mg and…
Submission based on positive results from Phase 3 PHALCON-NERD-301 in which vonoprazan 10 mg and…
PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech…
PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech…
Available clinical data from the two adult patients dosed with TSHA-102 in the first cohort…
Available clinical data from the two adult patients dosed with TSHA-102 in the first cohort…
– A special 510(k), according to FDA guidance, is usually reviewed within 30 days of…
– A special 510(k), according to FDA guidance, is usually reviewed within 30 days of…
Completed enrollment of patient expansion cohort of 20 patients at the RP2D of 4 mg/kg…
Completed enrollment of patient expansion cohort of 20 patients at the RP2D of 4 mg/kg…
Global multi-arm Phase 2 clinical trial expected to launch in 2024 SAN FRANCISCO, Sept. 26,…
Global multi-arm Phase 2 clinical trial expected to launch in 2024 SAN FRANCISCO, Sept. 26,…
ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or…